SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001013762-23-004638
Filing Date
2023-10-18
Accepted
2023-10-18 08:30:11
Documents
13
Period of Report
2023-10-12
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea186892-8k_biomx.htm   iXBRL 8-K 31508
  Complete submission text file 0001013762-23-004638.txt   253336

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE phge-20231012.xsd EX-101.SCH 3928
3 XBRL DEFINITION FILE phge-20231012_def.xml EX-101.DEF 26858
4 XBRL LABEL FILE phge-20231012_lab.xml EX-101.LAB 37192
5 XBRL PRESENTATION FILE phge-20231012_pre.xml EX-101.PRE 25482
7 EXTRACTED XBRL INSTANCE DOCUMENT ea186892-8k_biomx_htm.xml XML 5776
Mailing Address 22 EINSTEIN ST., 4TH FLOOR NESS ZIONA L3 7414003
Business Address 22 EINSTEIN ST., 4TH FLOOR NESS ZIONA L3 7414003 (972) 72 394 2377
BiomX Inc. (Filer) CIK: 0001739174 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38762 | Film No.: 231330978
SIC: 2836 Biological Products, (No Diagnostic Substances)